the emerging role of menin inhibitors in the treatment of npm1-mutated and kmt2a-rearranged r/r aml
Published 1 year ago • 431 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:40
the role of menin inhibitors in the treatment of aml
-
1:27
the role of menin inhibitors in the treatment of hr-mds and aml
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
1:38
the potential of menin inhibitors in specific molecular subsets of aml & all
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
7:27
menin inhibitors in aml: mechanism of action, the current key data, and predicting efficacy
-
1:14
promising novel agents in aml: menin inhibitors
-
2:38
emerging strategies for the management of relapsed aml
-
13:17
what should clinicians know about treating aml in 2023?
-
1:32
novel treatment combinations for flt3-mutated aml
-
0:41
promising agents in aml: menin inhibitors & magrolimab in tp53-mutated aml
-
2:01
the future of menin inhibitors in aml
-
1:22
the promise of menin inhibition in aml
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
2:22
development of novel menin-mll inhibitors for acute leukemias
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
4:38
menin inhibition in relapsed/refractory aml: what do the data tell us?
-
3:07
the impact of blast enumeration & co-occurring myelodysplasia-related mutations in npm1-mutated aml
-
4:38
menin inhibition in relapsed/refractory aml: what do the data tell us?
-
1:56
mrd negativity in npm1-mutated aml: the influence of co-occurring mutations and flag-ida induction
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl